Role and Diagnostic Significance of Apolipoprotein D in Selected Neurodegenerative Disorders DOI Creative Commons
Agata Kolanek,

Roman Cemaga,

Mateusz Maciejczyk

et al.

Diagnostics, Journal Year: 2024, Volume and Issue: 14(24), P. 2814 - 2814

Published: Dec. 14, 2024

The World Health Organization in 2021 ranked Alzheimer’s disease and other dementias as the seventh leading cause of death globally. Neurodegenerative disorders are progressive, intractable, often fatal diseases. Early diagnosis may allow patients to enjoy prolonged survival with attenuated symptomatology because early intervention. Hence, further research on finding non-invasive biomarkers neurodegenerative diseases is warranted. Apolipoprotein D (ApoD) a glycoprotein involved lipid metabolism, oxidative stress regulation, inflammation. It expressed various body fluids regions central nervous system. ApoD’s roles neuroprotection, transport, anti-inflammatory processes crucial far prevention pathologies concerned. This review aims summarize background knowledge ApoD, it covers studies indexed PubMed, Scopus, Web Science databases. discusses evidence for multifaceted ApoD mechanisms pathogenesis multiple sclerosis, disease, Parkinson’s disease. be specific, sensitive, easily obtained, cost-effective biomarker its applications diagnostic practices, treatment strategies, advancing disorders’ management.

Language: Английский

Changes in rat plasma proteomes during the first week after birth DOI Creative Commons
Lilong Wei, Zhengguang Guo, Jing Wei

et al.

Frontiers in Veterinary Science, Journal Year: 2025, Volume and Issue: 12

Published: Feb. 25, 2025

Blood plasma is the most informative body fluid, containing large amounts of substances that are released by active secretion or leakage from tissues and cells. Therefore, changes reflect state. To explore in during early life Wistar-rats, proteomes newborn first-week rats were investigated using liquid chromatography-tandem mass spectrometry. A total 639 proteins identified at both developmental stages 570 used for quantitative analysis. The rats, compared to label-free quantification, showed levels 42 significantly increased while those 17 decreased. Plasma proteomic patterns can be easily separated differential protein cluster Using Ingenuity Pathway analysis tool, some pathways including LXR/RXR Activation, DHCR24 Signaling Pathway, Acute Phase Response Signaling, Detoxification Reactive Oxygen Species enhanced. Over 10 categories related development functions enriched. distinct rats. These would make it easier survive. This first study spectrometry investigate rat proteome changes, providing a basis clues studying animal development.

Language: Английский

Citations

0

Apolipoproteins in ischemic stroke progression and recovery: Key molecular mechanisms and therapeutic potential DOI Creative Commons

Tamara Etuzé,

Hortense Triniac,

Ze Zheng

et al.

Neurobiology of Disease, Journal Year: 2025, Volume and Issue: unknown, P. 106896 - 106896

Published: April 1, 2025

Ischemic stroke, responsible for 80 % of all strokes, is a leading cause mortality globally. While altered lipids profiles are recognized as modifiable risk factors, their direct impact on stroke outcomes less understood due to the brain's distinct lipid metabolism and selective permeability blood-brain barrier lipoproteins. As key components lipoproteins, apolipoproteins essential transport, redistribution in both central nervous system peripheral blood circulation. This review provides an updated perspective influence brain-expressed (such ApoE, ApoA-I, ApoJ, ApoD, others) those that cross damaged following ischemic stroke. We explore hypotheses regarding involvement molecular pathways related metabolism, inflammation, oxidative stress, mitochondrial function integrity. Through this synthesis, we aim identify potential biomarkers therapeutic targets, thereby enhancing our understanding progression contributing improved clinical outcomes.

Language: Английский

Citations

0

Apolipoproteins and Lipoproteins in Health and Disease 2.0 DOI Open Access
Noemí Rotllán, Joan Carles Escolà‐Gil

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(11), P. 6183 - 6183

Published: June 4, 2024

Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide, accounting for 32% global deaths, according to World Health Organization (WHO) [...]

Language: Английский

Citations

0

Bidirectional Mendelian randomization analysis of plasma lipidome and psychiatric disorders DOI Creative Commons

Ling Yu,

Qing Long,

Yunqiao Zhang

et al.

Journal of Affective Disorders, Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 1, 2024

Language: Английский

Citations

0

Role and Diagnostic Significance of Apolipoprotein D in Selected Neurodegenerative Disorders DOI Creative Commons
Agata Kolanek,

Roman Cemaga,

Mateusz Maciejczyk

et al.

Diagnostics, Journal Year: 2024, Volume and Issue: 14(24), P. 2814 - 2814

Published: Dec. 14, 2024

The World Health Organization in 2021 ranked Alzheimer’s disease and other dementias as the seventh leading cause of death globally. Neurodegenerative disorders are progressive, intractable, often fatal diseases. Early diagnosis may allow patients to enjoy prolonged survival with attenuated symptomatology because early intervention. Hence, further research on finding non-invasive biomarkers neurodegenerative diseases is warranted. Apolipoprotein D (ApoD) a glycoprotein involved lipid metabolism, oxidative stress regulation, inflammation. It expressed various body fluids regions central nervous system. ApoD’s roles neuroprotection, transport, anti-inflammatory processes crucial far prevention pathologies concerned. This review aims summarize background knowledge ApoD, it covers studies indexed PubMed, Scopus, Web Science databases. discusses evidence for multifaceted ApoD mechanisms pathogenesis multiple sclerosis, disease, Parkinson’s disease. be specific, sensitive, easily obtained, cost-effective biomarker its applications diagnostic practices, treatment strategies, advancing disorders’ management.

Language: Английский

Citations

0